Clinical Trials Sponsored by DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (German Cancer Research Center)

Total 83 results

German Cancer Research Center
University of Heidelberg Medical Center; Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Exercise Intervention Study for Pancreatic Cancer Patients (SUPPORT)

Pancreatic Cancer

Germany
German Cancer Research Center
Heidelberg University

Active, not recruiting

Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging

Multiple Myeloma | Osteoporosis | Vertebral Fracture

Germany
German Cancer Research Center
Heidelberg University

Completed

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Gastrointestinal Neoplasms | Hodgkin Disease | Weight Loss | Non-Hodgkin Lymphoma | Bronchial Carcinoma

Germany
German Cancer Research Center
Heidelberg University

Completed

Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer (IMPACT2010)

Primarily Resectable Pancreatic Cancer

Germany
Heidelberg University
German Cancer Research Center

Unknown

Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial] (POUDER)

Pancreatic Ductal Adenocarcinoma

Germany
German Cancer Research Center
Heidelberg University

Completed

MOTIVACTION - Study

Cancer

Germany
Heidelberg University
German Cancer Research Center

Completed

Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma (NeoWTS)

Soft Tissue Sarcoma

Germany
German Cancer Research Center
Heidelberg University

Completed

Exercise Study in Patients With Lung Cancer (POSITIVE)

Non Small Cell Lung Cancer

Germany
German Cancer Research Center
University Hospital Heidelberg

Recruiting

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma (IntenSify)

Pancreatic Cancer | Pancreatic Adenocarcinoma | CYP3A Inhibitor | Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm

Germany
German Cancer Research Center
University Hospital Heidelberg

Recruiting

CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer (CATCH)

Metastatic Breast Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
German Cancer Research Center
University Hospital Heidelberg

Active, not recruiting

Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy (BENEFIT)

Breast Cancer

Germany
German Cancer Research Center
University Hospital Heidelberg

Completed

Nutrition and Energy Restriction for Cancer Prevention (HELENA)

Metabolic Diseases | Obesity | Weight Loss | Body Composition, Beneficial | Visceral Obesity

Germany
German Cancer Research Center
University Hospital Heidelberg

Withdrawn

Longitudinal Investigation of Cancer-related Fatigue (LIFT)

Cancer-related Fatigue
University Hospital Heidelberg
German Cancer Research Center

Completed

Mitochondrial Effects of C18:0 Supplementation in Humans

Type2 Diabetes | Fatty Acid Deficiency | Alteration of Mitochondrial Membrane

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Active, not recruiting

Tumor-specific T Cells in Lung Cancer

Non-small Cell Lung Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Completed

Immune Boost In Non-Small Cell Lung Cancer (RadImmune)

Non-small Cell Lung Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center

Recruiting

Systematic Evaluation of Human Explant Model Systems Engineering (SEEDLING)

Solid Tumor, Adult

Germany
University Hospital Heidelberg
German Cancer Research Center

Completed

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Colorectal Cancer Metastatic | Pancreatic Cancer Metastatic

Germany
German Cancer Research Center
University Hospital Heidelberg

Completed

Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer (SMART)

Hematologic Diseases | Treatment

Germany
University Hospital Heidelberg
German Cancer Research Center

Completed

Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)

Retroperitoneal Soft Tissue Sarcoma

Germany
University Hospital Heidelberg
German Cancer Research Center

Unknown

Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NEOPANC)

Pancreatic Neoplasms

Germany
University Hospital Heidelberg
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer Aid

Completed

NCT Neuro Master Match - N²M² (NOA-20) (N²M²)

Glioblastoma, Adult

Germany
Heidelberg University
University of Heidelberg Medical Center; German Cancer Research Center; National... and other collaborators

Completed

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Breast Cancer | Colorectal Cancer | Prostate Cancer | Physicians | Nurses
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training (PIC)

Exercise | Chemotherapy-induced Polyneuropathy

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

POSITIVE - Study (Part III) Heidelberg (POSITIVE)

Advanced NSCLC | First Line Treatment

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (BEST)

Breast Cancer | Cancer-related Fatigue

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers (PANHPVAX)

HPV

Germany
German Cancer Research Center
National Center for Tumor Diseases, Heidelberg

Recruiting

A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening (MERLIN)

Cancer-related Fatigue

Germany
National Center for Tumor Diseases, Heidelberg
German Cancer Research Center; University Hospital Heidelberg

Terminated

Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer (ATACC)

Colorectal Carcinoma

Germany
German Cancer Research Center
Mukoviszidose Institut gGmbH; Heidelberg University

Completed

Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)

Cystic Fibrosis | Lung Disease

Germany
German Cancer Research Center
German Federal Ministry of Education and Research; Heidelberg University

Completed

Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice (DIANA)

Type 2 Diabetes Mellitus

Germany
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Active, not recruiting

OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma (OPPOSITE)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Terminated

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival (PERDAM)

Leukemia, Myeloid, Acute

Germany
German Cancer Research Center
Heidelberg University; Technical University of Munich

Withdrawn

Strength Training on Pancreatic Cancer (STOPC)

Pancreatic Neoplasms | Cachexia | Myopathy

Germany
German Cancer Research Center
German Federal Ministry of Education and Research; University Hospital Heidelberg

Recruiting

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (COGNITION)

Neoadjuvant Therapy | Early-Stage Breast Cancer

Germany
University of Heidelberg Medical Center
German Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials Heidelberg

Active, not recruiting

BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA) (GMMG-BIRMA)

Relapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K Mutation

Germany
Heidelberg University
German Center for Lung Research

Recruiting

Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening (TRACK-CF)

Cystic Fibrosis Lung Disease

Germany
National Center for Tumor Diseases, Heidelberg
AstraZeneca; German Cancer Research Center; PharmaMar

Completed

Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603)

Cancers With DNA Repair-Deficiency

Germany
Heidelberg University
German Center for Lung Research

Completed

Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis (PRESIS)

Cystic Fibrosis Lung Disease

Germany
National Center for Tumor Diseases, Heidelberg
German Cancer Research Center; University Hospital Heidelberg; Neuro-Oncology...

Completed

Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas (NOA-16)

Glioma

Germany
Heidelberg University
GlaxoSmithKline; German Cancer Research Center; University Hospital Heidelberg; Universitätsmedizin Mannheim and other collaborators

Terminated

Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma (NOPASS)

Sarcoma, Soft-tissue

Germany
University of Heidelberg Medical Center
German Research Foundation

Completed

Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa

Healthy | Anorexia Nervosa

Germany
German Cancer Research Center
University of Leipzig; Heidelberg University; University Hospital Heidelberg; Children...

Completed

Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment (ONKOKIDS-HD)

Childhood Cancer

Germany
Technische Universität Dresden
German Cancer Research Center; National Center for Radiation Research in Oncology...

Recruiting

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Brain Tumors

Germany
Michael Dill
University of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaborators

Not yet recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)

Immunotherapy

Germany
Technische Universität Dresden
German Cancer Research Center; National Center for Radiation Research in Oncology...

Recruiting

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer (PRONTOX)

Non-Small Cell Lung Cancer

Germany
German Cancer Research Center
University Hospital Heidelberg; Central Institute of Mental Health, Mannheim; National Center for Tumor Diseases, Heidelberg

Completed

Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA) (PETRA)

Allogeneic Stem Cell Transplantation

Germany
German Cancer Research Center
University Hospital Heidelberg; Central Institute of Mental Health, Mannheim; National Center for Tumor Diseases, Heidelberg

Completed

Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life (BEATE)

Breast Cancer | Cancer-related Fatigue

Germany

Clinical Trials Sponsored by DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (German Cancer Research Center)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations